Fayerweather Charles’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$550K Hold
16,800
0.96% 32
2020
Q1
$505K Hold
16,800
1.07% 32
2019
Q4
$487K Hold
16,800
0.81% 36
2019
Q3
$434K Sell
16,800
-3,000
-15% -$75.9K 0.77% 36
2019
Q2
$506K Hold
19,800
0.76% 35
2019
Q1
$518K Hold
19,800
0.81% 34
2018
Q4
$456K Hold
19,800
0.81% 35
2018
Q3
$467K Sell
19,800
-1,000
-5% -$24.4K 0.72% 39
2018
Q2
$479K Sell
20,800
-2,200
-10% -$52.3K 0.77% 38
2018
Q1
$566K Sell
23,000
-2,900
-11% -$76.1K 0.9% 34
2017
Q4
$695K Sell
25,900
-1,400
-5% -$35.6K 1.02% 33
2017
Q3
$657K Sell
27,300
-80
-0.3% -$1.81K 0.86% 37
2017
Q2
$587K Sell
27,380
-2,600
-9% -$52.5K 0.79% 39
2017
Q1
$514K Sell
29,980
-3,500
-10% -$60.9K 0.73% 40
2016
Q4
$600K Hold
33,480
0.89% 35
2016
Q3
$696K Sell
33,480
-100
-0.3% -$2.48K 0.98% 36
2016
Q2
$904K Hold
33,580
1.26% 26
2016
Q1
$909K Buy
33,580
+5,680
+20% +$152K 1.28% 24
2015
Q4
$810K Buy
27,900
+19,400
+228% +$537K 1.34% 26
2015
Q3
$231K Hold
8,500
0.63% 45
2015
Q2
$233K Hold
8,500
0.59% 47
2015
Q1
$227K Buy
+8,500
New +$196K 0.57% 48
2014
Q4
Sell
-8,500
Closed -$202K 46
2014
Q3
$202K Buy
+8,500
New +$196K 0.7% 43

Other funds holding NVO

Fayerweather Charles's NVO Position: Q2 2020 in Review

Fayerweather Charles held its Novo Nordisk (NVO) position steady in Q2 2020 at 16,800 shares worth $550K. The position accounts for 0.96% of the portfolio, ranked #32.

Fayerweather Charles first reported a position in NVO in Q3 2014 and has held it in 23 quarters since. The position peaked at $909K in Q1 2016. 661 funds tracked by Wall St. Rank hold NVO as of Q2 2020.

  • Fayerweather Charles held 16,800 shares of Novo Nordisk worth $550K as of Q2 2020.
  • Fayerweather Charles left its Novo Nordisk share count unchanged in Q2 2020.
  • Novo Nordisk made up 0.96% of Fayerweather Charles's portfolio in Q2 2020, its #32 holding.
  • Fayerweather Charles first reported a position in Novo Nordisk in Q3 2014 and has held it in 23 quarters since.
  • Fayerweather Charles's Novo Nordisk position peaked at $909K in Q1 2016.
  • 661 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2020.

Based on Fayerweather Charles's 13F filing for Q2 2020, filed 28 Jul 2020.